Pliant Therapeutics Files 8-K
Ticker: PLRX · Form: 8-K · Filed: Feb 13, 2025 · CIK: 1746473
| Field | Detail |
|---|---|
| Company | Pliant Therapeutics, Inc. (PLRX) |
| Form Type | 8-K |
| Filed Date | Feb 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, corporate-update
TL;DR
Pliant Therapeutics filed an 8-K on Feb 13, 2025. Details TBD.
AI Summary
Pliant Therapeutics, Inc. filed an 8-K on February 13, 2025, reporting other events and financial statements. The filing does not contain specific financial figures or details about the 'other events' beyond its classification.
Why It Matters
This filing indicates Pliant Therapeutics is providing updates to the SEC, which could relate to ongoing clinical trials, financial status, or other corporate developments.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and financial statements without specific material disclosures that would immediately impact risk.
Key Players & Entities
- PLIANT THERAPEUTICS, INC. (company) — Registrant
- February 13, 2025 (date) — Date of earliest event reported
- 001-39303 (other) — SEC File Number
- 47-4272481 (other) — IRS Employer Identification No.
- 331 Oyster Point Blvd, South San Francisco, CA 94080 (address) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by Pliant Therapeutics in this 8-K?
The filing indicates 'Other Events' are being reported, but the specific details of these events are not elaborated upon in the provided text.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is February 13, 2025.
What is Pliant Therapeutics' SEC file number?
Pliant Therapeutics' SEC file number is 001-39303.
Where are Pliant Therapeutics' principal executive offices located?
Pliant Therapeutics' principal executive offices are located at 331 Oyster Point Blvd, South San Francisco, CA 94080.
What is the SIC code for Pliant Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Pliant Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 499 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-02-13 09:00:18
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share PLRX The Nasdaq Stock Mar
Filing Documents
- d892128d8k.htm (8-K) — 24KB
- d892128dex991.htm (EX-99.1) — 9KB
- g892128g0213080258357.jpg (GRAPHIC) — 2KB
- 0001193125-25-025663.txt ( ) — 156KB
- plrx-20250213.xsd (EX-101.SCH) — 3KB
- plrx-20250213_lab.xml (EX-101.LAB) — 17KB
- plrx-20250213_pre.xml (EX-101.PRE) — 11KB
- d892128d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated February 13, 2025, titled "Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis." 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PLIANT THERAPEUTICS, INC. Date: February 13, 2025 By: /s/ Keith Cummings Keith Cummings, M.D., MBA Chief Financial Officer